Font Size: a A A
Keyword [EML4]
Result: 21 - 40 | Page: 2 of 3
21. Role Of Stat3/Survivin Signaling Pathway In The EML4-ALK Positive Lung Adenocarcinoma Cell-Line H2228 Before And After Crizotinib Induced Resistance
22. Influence Of BIM Signaling Pathway In EML4-ALK Positive Lung Adenocarcinoma Cell-Line H2228 After Crizotinib Induced Resistance
23. Relations Of EML4-ALK Fusion Gene And The MRNA Expression Of TYMS In Patients With Lung Adenocarcinoma Tissue
24. Study Of EML4-ALK Fusion Gene In The Primary And Metastases Tumor Tissues And The Serum Of VEGF In Non-small Cell Lung Cancer Patients
25. The Structure Analysis Of EML4-ALK Fusion Genelociand The Association Study Between-308 Signal Nucleotidepolymorphism(SNP) Of TNF-α Gene And Primary Lung Cancer
26. The Association Analysis Between Driver Gene Mutations Of EGFRKRASEML4-ALK And Clinical Features Of Patients Of Lung Cancer
27. ALK Associated NSCLC:Study And Perspective Of Immunohistochemical Screening And EML4-ALK Fusion Heterogeneity
28. Establishment Of Crizotinib-resistant Cell Line H3122 Of Non-small Cell Lung Cancer And Underlying Resistance Mechanisms
29. Role Of MTOR Signaling Pathway In 17-DMAG Overcoming Acquire Resistance To Alectinib In EML4–ALK Positive Lung Cancer Cell Line H3122
30. Efficacy Of Crizotinib In Advanced EML4-ALK Positive Non-small Cell Lung Cancer
31. By Pass Signaling Pathways Activation Mediated Resistance To Alectinib In EML4-ALK Fusion Gene Positive Lung Cancer Cell Line H3122
32. Noninvasive Detection Of EML4-ALK Fusion Gene
33. Detection Of EML4-ALK Fusion Gene And Analysis Of Its Clinical Features In NSCLC Patients With EML4-ALK Fusion Gene
34. An Exploratory Study On Screening Of Spcific Peptides In Patients With ALK+NSCLC And Crizotinib Efficacy Related Peptides By Serum Mass Spectrum
35. The Effects And Methylation Status Of SOCS1 And SOCS3 Gene Promoter In EML4-ALK Positive H2228 Lung Cancer Cells
36. Correlation Study Of EGFR And ALK Expression In Lung Adenocarcinoma Based On Spectral CT Parameters
37. The Anti-tumor Effect Of A Novel ALK/ROS1 Dual Target Inhibitors ZX-29 In Vitro And The Mechanism Of Drug Resistance Result From By ROS1 Mutation
38. Research On The Reference Material For EML4-ALK Fusion Gene Detection Based On CRISPR/CAS9 Technology
39. Expression And Significance Of PD-1 And PD-L1 In Non-Small Cell Lung Cancer In Yunnan Xuanwei Region
40. Meteormin Restore Alectinib Sensitivty In H3122 Cells Through Inhibition Of IGF-1R/PI3K/AKT/mTOR Signalingpathway
  <<First  <Prev  Next>  Last>>  Jump to